Ludmila Sidorenko

Dr. Ludmila Sidorenko

Sate University of medicine and Pharmacy Nicoale Testemitanu,, Chisinau, Chişinău, Moldova
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2024 in Algorithms
Verified
Journal Article
Open access
PDF file
Niels WesselNiels Wessel
Niels Wessel
MSMariana Sprincean
Mariana Sprincean
LSLudmila Sidorenko
Ludmila Sidorenko
NRNinel Revenco
Ninel Revenco
SHSvetlana Hadjiu
Svetlana Hadjiu
Childhood stroke can lead to lifelong disability. Developing algorithms for timely recognition of clinical and paraclinical signs is crucial to ensure prompt stroke diagnosis and minimize decision-making time. This study aimed to characterize clinical and paraclinical symptoms of childhood and neonatal stroke as relevant diagnostic criteria encountered in clinical practice, in order to develop algorithms for prompt stroke diagnosis. The analysis included data from 402 pediatric case histories from 2010 to 2016 and 108 prospective stroke cases from 2017 to 2020. Stroke cases were predominantly diagnosed in newborns, with 362 (71%, 95% CI 68.99–73.01) cases occurring within the first 28 days of birth, and 148 (29%, 95% CI 26.99–31.01) cases occurring after 28 days. The findings of the study enable the development of algorithms for timely stroke recognition, facilitating the selection of optimal treatment options for newborns and children of various age groups. Logistic regression serves as the basis for deriving these algorithms, aiming to initiate early treatment and reduce lifelong morbidity and mortality in children. The study outcomes include the formulation of algorithms for timely recognition of newborn stroke, with plans to adopt these algorithms and train a fuzzy classifier-based diagnostic model using machine learning techniques for efficient stroke recognition.

5 July 2023 in Entropy
Verified
Journal Article
Open access
PDF file
LSLudmila Sidorenko
Ludmila Sidorenko
ASAnatolie Sidorenko
Anatolie Sidorenko
AGAndrej Gapelyuk
Andrej Gapelyuk
Niels WesselNiels Wessel
Niels Wessel
Cardiovascular diseases are the leading cause of morbidity and mortality in adults worldwide. There is one common pathophysiological aspect present in all cardiovascular diseases—dysfunctional heart rhythm regulation. Taking this aspect into consideration for cardiovascular risk predictions opens important research perspectives, allowing for the development of preventive treatment techniques. The aim of this study was to find out whether certain pathologically appearing signs in the heart rate variability (HRV) of an apparently healthy person, even with high HRV, can be defined as biomarkers for a disturbed cardiac regulation and whether this can be treated preventively by a drug-free method. This multi-phase study included 218 healthy subjects of either sex, who consecutively visited the physician at Gesundheit clinic because of arterial hypertension, depression, headache, psycho-emotional stress, extreme weakness, disturbed night sleep, heart palpitations, or chest pain. In study phase A, baseline measurement to identify individuals with cardiovascular risks was done. Therefore, standard HRV, as well as the new cardiorhythmogram (CRG) method, were applied to all subjects. The new CRG analysis used here is based on the recently introduced LF drops and HF counter-regulation. Regarding the mechanisms of why these appear in a steady-state cardiorhythmmogram, they represent non-linear event-based dynamical HRV biomarkers. The next phase of the study, phase B, tested whether the pathologically appearing signs identified via CRG in phase A could be clinically influenced by drug-free treatment. In order to validate the new CRG method, it was supported by non-linear HRV analysis in both phase A and in phase B. Out of 218 subjects, the pathologically appearing signs could be detected in 130 cases (60%), p < 0.01, by the new CRG method, and by the standard HRV analysis in 40 cases (18%), p < 0.05. Thus, the CRG method was able to detect 42% more cases with pathologically appearing cardiac regulation. In addition, the comparative CRG analysis before and after treatment showed that the pathologically appearing signs could be clinically influenced without the use of medication. After treatment, the risk group decreased eight-fold—from 130 people to 16 (p < 0.01). Therefore, progression of the detected pathological signs to structural cardiac pathology or arrhythmia could be prevented in most of the cases. However, in the remaining risk group of 16 apparently healthy subjects, 8 people died due to all-cause mortality. In contrast, no other subject in this study has died so far. The non-linear parameter which is able to quantify the changes in CRGs before versus after treatment is FWRENYI4 (symbolic dynamic feature); it decreased from 2.85 to 2.53 (p < 0.001). In summary, signs of pathological cardiac regulation can be identified by the CRG analysis of apparently healthy subjects in the early stages of development of cardiac pathology. Thus, our method offers a sensitive biomarker for cardiovascular risks. The latter can be influenced by non-drug treatments (acupuncture) to stop the progression into structural cardiac pathologies or arrhythmias in most but not all of the patients. Therefore, this could be a real and easy-to-use supplemental method, contributing to primary prevention in cardiology.

12 September 2023
Verified
Book Chapter
Closed access
PDF file
LSLudmila Sidorenko
Ludmila Sidorenko
ISIrina Sidorenko
Irina Sidorenko
RCRoman Chornopyshchuk
Roman Chornopyshchuk
ICIgor Cemortan
Igor Cemortan
SCSvetlana Capcelea
Svetlana Capcelea
Niels WesselNiels Wessel
Niels Wessel

30 March 2026 in Innovative technologies and scientific solutions for industries
Verified
Journal Article
Open access
AKAlexander Krajči
Alexander Krajči
LSLudmila Sidorenko
Ludmila Sidorenko
OBOlesia Barkovska
Olesia Barkovska
Relevance. Cardiovascular diseases remain a leading cause of mortality globally, creating a high demand for automated diagnostic systems. However, developing reliable machine learning models for electrocardiogram (ECG) analysis is often hindered by the availability of only small-scale and imbalanced datasets, which limits the effectiveness of deep learning approaches. The object of research is the process of automated processing and classification of electrocardiographic signals for diagnostic purposes. The subject of the research includes methods of beat-centric feature extraction, patient-level aggregation strategies, and machine learning algorithms for cardiovascular risk prediction. The purpose of this paper is to develop and evaluate a reliable classification framework, optimized for small datasets, that increases prediction accuracy by leveraging patient-level feature aggregation and explainable machine learning models. To achieve this goal, the following tasks were solved: 1) implementation of a robust preprocessing pipeline using a refined Pan-Tompkins algorithm for precise beat-centric segmentation; 2) development of a statistical feature aggregation strategy to mitigate local signal variability; and 3) optimization and validation of a Random Forest classifier. The methodology employed includes digital signal processing (Butterworth filtering), advanced feature engineering (HRV, Wavelets analysis), and rigorous 10-fold Stratified Cross-Validation to ensure generalization on limited data. Research results. The study proposes a pipeline initiating with standard signal preprocessing, followed by precise R-peak detection and beat-centric segmentation. Physiological features (HRV, wavelet, morphological) are then extracted from individual segments and statistically aggregated at the patient level. Experiments on a dataset of 164 subjects demonstrated that the proposed patient-level aggregation strategy significantly outperformed traditional segment-based analysis. The final Random Forest model achieved an ROC-AUC score of 0.84. Feature importance analysis confirmed the critical role of Heart Rate Variability (HRV) metrics, particularly SDNN and RMSSD, in differentiating between healthy and high-risk subjects.

14 March 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MSMariana Sprincean
Mariana Sprincean
LSLudmila Sidorenko
Ludmila Sidorenko
SSSerghei Sprincean
Serghei Sprincean
SHSvetlana Hadjiu
Svetlana Hadjiu
Niels WesselNiels Wessel
Niels Wessel
Introduction: Pediatric ischemic stroke (IS) is a rare but severe neurological emergency, with an incidence of 2–13 per 100,000. Most cases occur in the prenatal period or early infancy. Integrating artificial intelligence (AI) into clinical practice may enhance the early recognition of stroke. This pilot study aimed to identify immunoenzymatic markers as early predictors of pediatric IS, supporting machine learning applications. Materials and Methods: A prospective study (2017–2019) in Moldova included 53 children with IS and 53 healthy controls. The serum levels of vascular endothelial growth factor (VEGF), ciliary neurotrophic factor (CNTF), the S100B protein, CD105 (endoglin), antiphospholipid antibodies (APAs), and interleukin-6 (IL-6) were measured using ELISA during the acute phase. Results: Endoglin levels were significantly lower in IS patients (2.06 ± 0.012 ng/mL) vs. controls (2.51 ± 0.071 ng/mL) (p < 0.001). S100B levels were elevated (0.524 ± 0.0850 ng/mL vs. 0.120 ± 0.0038 ng/mL, p < 0.01). VEGF levels were significantly increased (613.41 ± 39.299 pg/mL vs. 185.50 ± 12.039 pg/mL, p < 0.001), correlating with the infarct size and disease severity. CNTF levels were also higher (7.84 ± 0.322 pg/mL vs. 5.29 ± 0.067 pg/mL, p < 0.001). APA levels were elevated (1.37 ± 0.046 U/mL vs. 0.92 ± 0.021 U/mL, p < 0.001). IL-6 levels were 10 times higher in IS patients (22.02 ± 2.143 pg/mL vs. 2.38 ± 0.302 pg/mL, p < 0.001), correlating with the infarct size (p < 0.004) and neurological prognosis at six months (p < 0.01). Conclusions: IL-6, VEGF, CNTF, S100B, CD105, and APAs are key markers in pediatric IS, reflecting neuroinflammation, vascular disruption, and the long-term prognosis. Their integration into AI-driven diagnostic models may improve early stroke detection and pediatric monitoring.

30 September 2021 in Medical Science of Ukraine (MSU)
Verified
Journal Article
Open access
PDF file
RCR.M. Chornopyshchuk
R.M. Chornopyshchuk
VNV.I. Nagaichuk
V.I. Nagaichuk
IGI.I. Gerashchenko
I.I. Gerashchenko
ONO.A. Nazarchuk
O.A. Nazarchuk
SSS.A. Sidorenkov
S.A. Sidorenkov
LSLudmila Sidorenko
Ludmila Sidorenko
Relevance.One of the promising methods of treatment of patients with burns is the local use of sorption agents with antimicrobial properties. Objective: experimental study of antimicrobial properties and clinical evaluation of the effectiveness of local use of a new sorption composition based on nanosilica in the complex treatment of patients with burns. Materials and methods. The suggested sorption nanocomposition included highly dispersed silicon dioxide, polymethylsiloxane, decamethoxine, metronidazole. The experimental study involved the study of the antimicrobial properties of the sorption nanocomposition and antimicrobial agents which are part of it. The clinical material consisted of the results of examination of 42 patients with IIab-III degree burns with an area of 10-30% of the body surface. Depending on the tactics of local treatment, patients were divided into 2 groups: after early necrectomy, xenodermoplasty, the wound surface of the patients in the main group (n = 20) was treated with a solution of decamethoxine in combination with the same sorption powder. Treatment in the comparison group (n = 22) was similar except the use of sorption drugs. The examination included visual inspection of the injured area in combination with microbiological monitoring of the wound contents on the 3rd,7th,14th day. Results. The obtained results confirmed the sufficient antimicrobial potential of the studied sorption nanocomposition, the properties of which are not inferior to the existing antiseptics for museum and clinical strains of microorganisms and fungi. Signs of a more favorable wound healing process of the patients in the main group were observed: faster wound cleaning, less inflammatory reactions and much shorter preparation of wounds for grafting. Conclusions. The obtained results convincingly indicate the effectiveness of a multicomponent composite based on nanosilica with antimicrobial components in a comprehensive treatment of patients with burns.